Alliancebernstein L.P. Madrigal Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 27,900 shares of MDGL stock, worth $6.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,900

Previous 339,754 91.79%

Holding current value

$6.59 Million

Previous $78.6 Million 90.52%

% of portfolio

0.0%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$171.37 - $283.23 $53.4 Million - $88.3 Million	-311,854 Reduced 91.79%	27,900 $7.45 Million
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $2.56 Million - $5.03 Million	-21,223 Reduced 5.88%	339,754 $78.6 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $1.48 Million - $2.29 Million	-10,139 Reduced 2.73%	360,977 $52.7 Million
Q2 2023 Aug 15, 2023	BUY	$203.88 - $312.0 $70.8 Million - $108 Million	347,448 Added 1468.01%	371,116 $85.7 Million
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $300,378 - $399,204	-1,300 Reduced 5.21%	23,668 $5.73 Million

Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $482,768 - $2.45 Million	8,268 Added 49.51%	24,968 $7.25 Million
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $5,589 - $10,189	100 Added 0.6%	16,700 $1.64 Million
Q1 2021 May 06, 2021	SELL	$108.54 - $125.2 $35 Million - $40.4 Million	-322,314 Reduced 95.1%	16,600 $1.94 Million
Q4 2020 Feb 08, 2021	SELL	$110.06 - $133.7 $24.8 Million - $30.1 Million	-225,048 Reduced 39.9%	338,914 $37.7 Million
Q3 2020 Nov 12, 2020	BUY	$99.78 - $124.21 $4.79 Million - $5.96 Million	47,968 Added 9.3%	563,962 $67 Million
Q2 2020 Aug 13, 2020	BUY	$60.13 - $125.71 $6.33 Million - $13.2 Million	105,230 Added 25.62%	515,994 $58.4 Million
Q1 2020 May 14, 2020	BUY	$66.76 - $93.49 $3.95 Million - $5.53 Million	59,123 Added 16.81%	410,764 $27.4 Million
Q4 2019 Feb 18, 2020	BUY	$84.28 - $118.5 $1.81 Million - $2.54 Million	21,444 Added 6.49%	351,641 $32 Million
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $240,118 - $303,077	2,845 Added 0.87%	330,197 $28.5 Million
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $1.62 Million - $2.53 Million	17,747 Added 5.73%	327,352 $34.3 Million
Q1 2019 May 14, 2019	BUY	$103.48 - $143.84 $359,179 - $499,268	3,471 Added 1.13%	309,605 $38.8 Million
Q4 2018 Feb 13, 2019	BUY	$94.77 - $215.54 $8.85 Million - $20.1 Million	93,374 Added 43.89%	306,134 $34.5 Million
Q3 2018 Nov 08, 2018	BUY	$207.3 - $300.31 $7.57 Million - $11 Million	36,532 Added 20.73%	212,760 $45.6 Million
Q2 2018 Aug 13, 2018	SELL	$101.55 - $313.9 $9.96 Million - $30.8 Million	-98,126 Reduced 35.77%	176,228 $49.3 Million
Q1 2018 May 14, 2018	BUY	$93.35 - $149.04 $23.9 Million - $38.2 Million	256,154 Added 1407.44%	274,354 $32 Million
Q4 2017 Feb 13, 2018	BUY	$39.35 - $97.37 $716,170 - $1.77 Million	18,200	18,200 $1.67 Million

Others Institutions Holding MDGL

# of Institutions

313

Shares Held

20M

Call Options Held

824K

Put Options Held

1.04M

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $4.04B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Madrigal Pharmaceuticals, Inc. Transaction History